AlphaFold predicted structure
FAM20A · Q96MK3

Mean pLDDT
85.3/ 100
Confident
541 residues
Confidence breakdown
- Very high(≥ 90)67%
- Confident(70–90)15%
- Low(50–70)6%
- Very low(< 50)12%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
FAM20A golgi associated secretory pathway pseudokinase
Annotations refreshed 11 hours ago.
Diagnostic Grade (Green)
Amelogenesis imperfecta
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalNephrocalcinosis or nephrolithiasis
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalamelogenesis imperfecta type 1G
Amelogenesis imperfecta and gingival hyperplasia syndrome
otosclerosis
Chorioretinal scar
Alzheimer disease
hearing loss, mixed conductive-sensorineural
cholelithiasis
hereditary disease
Carney complex, type 1
Acrodysostosis 1 with or without hormone resistance
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Pseudokinase FAM20A
Pseudokinase that acts as an allosteric activator of the Golgi serine/threonine protein kinase FAM20C and is involved in biomineralization of teeth. Forms a complex with FAM20C and increases the ability of FAM20C to phosphorylate the proteins that form the 'matrix' that guides the deposition of the enamel minerals
FAM20A · Q96MK3

Mean pLDDT
85.3/ 100
Confident
541 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0